{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:47:17Z","timestamp":1794264437853,"version":"4.9.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Identifying reliable prognostic markers is crucial for the effective management of hypertension. The neutrophil-to-lymphocyte ratio (NLR) has emerged as a potential inflammatory marker linked to cardiovascular outcomes. This study aims to investigate the association of NLR with all-cause and cardiovascular mortality among patients with hypertension.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study analyzed data from 3067 hypertensive adults in the National Health and Nutritional Examination Surveys (NHANES) from 2009 to 2014. Mortality details were obtained from the National Death Index (NDI). Restricted cubic spline (RCS) was deployed to visualize the association of the NLR with mortality risk. Weighted Cox proportional hazards models were employed to assess the independent association of NLR with mortality risk. Time-dependent receiver operating characteristic curve (ROC) analysis was conducted to access the predictive ability of NLR for survival. Mediation analysis was used to explore the indirect impact of NLR on mortality mediated through eGFR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Over a median 92.0-months follow-up, 538 deaths occurred, including 114 cardiovascular deaths. RCS analysis revealed a positive association between NLR and both all-cause and cardiovascular mortality. Participants were stratified into higher (&gt;\u20093.5) and lower (\u2264\u20093.5) NLR groups. Weighted Cox proportional hazards models demonstrated that individuals with higher NLR had a significantly increased risk of all-cause (HR 1.96, 95% confidence interval (CI) 1.52\u20132.52, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001) and cardiovascular mortality (HR 2.33, 95% CI 1.54\u20133.51, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Stratified and interaction analysis confirmed the stability of the core results. Notably, eGFR partially mediated the association between NLR and both all-cause and cardiovascular mortality by a 5.4% and 4.7% proportion, respectively. Additionally, the areas under the curve (AUC) of the 3-, 5- and 10- year survival was 0.68, 0.65 and 0.64 for all-cause mortality and 0.68, 0.70 and 0.69 for cardiovascular mortality, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Elevated NLR independently confers an increased risk for both all-cause and cardiovascular mortality in individuals with hypertension.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-024-02191-5","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T08:01:55Z","timestamp":1712044915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":147,"title":["The neutrophil-to-lymphocyte ratio is associated with all-cause and cardiovascular mortality among individuals with hypertension"],"prefix":"10.1186","volume":"23","author":[{"given":"Xuexue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wantong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiliang","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,2]]},"reference":[{"issue":"11","key":"2191_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41569-021-00559-8","volume":"18","author":"B Zhou","year":"2021","unstructured":"Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18(11):785\u2013802.","journal-title":"Nat Rev Cardiol"},{"issue":"10258","key":"2191_CR2","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"CJL Murray","year":"2020","unstructured":"Murray CJL, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, Abd-Allah F, Abdelalim A, Abdollahi M, Abdollahpour I, et al. Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223\u201349.","journal-title":"Lancet"},{"issue":"10304","key":"2191_CR3","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"B Zhou","year":"2021","unstructured":"Zhou B, Carrillo-Larco RM, Danaei G, Riley LM, Paciorek CJ, Stevens GA, Gregg EW, Bennett JE, Solomon B, Singleton RK, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957\u201380.","journal-title":"Lancet"},{"issue":"8","key":"2191_CR4","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y, et al. Heart disease and stroke statistics\u20142022 update: a report from the American Heart Association. Circulation. 2022;145(8):e153\u2013639.","journal-title":"Circulation"},{"issue":"8","key":"2191_CR5","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/CIRCRESAHA.122.321762","volume":"132","author":"M Burnier","year":"2023","unstructured":"Burnier M, Damianaki A. Hypertension as cardiovascular risk factor in chronic kidney disease. Circ Res. 2023;132(8):1050\u201363.","journal-title":"Circ Res"},{"issue":"18","key":"2191_CR6","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1001\/jama.2022.19590","volume":"328","author":"RM Carey","year":"2022","unstructured":"Carey RM, Moran AE, Whelton PK. Treatment of hypertension. JAMA. 2022;328(18):1849\u201361.","journal-title":"JAMA"},{"issue":"25","key":"2191_CR7","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1093\/eurheartj\/ehz300","volume":"40","author":"T Beaney","year":"2019","unstructured":"Beaney T, Burrell LM, Castillo RR, Charchar FJ, Cro S, Damasceno A, Kruger R, Nilsson PM, Prabhakaran D, Ramirez AJ, et al. May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension. Eur Heart J. 2019;40(25):2006\u201317.","journal-title":"Eur Heart J"},{"issue":"7","key":"2191_CR8","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jamacardio.2017.1658","volume":"2","author":"A Odutayo","year":"2017","unstructured":"Odutayo A, Gill P, Shepherd S, Akingbade A, Hopewell S, Tennankore K, Hunn BH, Emdin CA. Income disparities in absolute cardiovascular risk and cardiovascular risk factors in the United States, 1999\u20132014. JAMA Cardiol. 2017;2(7):782\u201390.","journal-title":"JAMA Cardiol"},{"issue":"13","key":"2191_CR9","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/jama.2021.15187","volume":"326","author":"J He","year":"2021","unstructured":"He J, Zhu Z, Bundy JD, Dorans KS, Chen J, Hamm LL. Trends in cardiovascular risk factors in US adults by race and ethnicity and socioeconomic status, 1999\u20132018. JAMA. 2021;326(13):1286\u201398.","journal-title":"JAMA"},{"issue":"07","key":"2191_CR10","doi-asserted-by":"publisher","first-page":"474","DOI":"10.4149\/BLL_2021_078","volume":"122","author":"R Zahorec","year":"2021","unstructured":"Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratislava Med J. 2021;122(07):474\u201388.","journal-title":"Bratislava Med J"},{"issue":"1","key":"2191_CR11","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12916-020-01817-1","volume":"18","author":"MA Cupp","year":"2020","unstructured":"Cupp MA, Cariolou M, Tzoulaki I, Aune D, Evangelou E, Berlanga-Taylor AJ. Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. BMC Med. 2020;18(1):360.","journal-title":"BMC Med"},{"issue":"3","key":"2191_CR12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ajem.2019.10.023","volume":"38","author":"Z Huang","year":"2020","unstructured":"Huang Z, Fu Z, Huang W, Huang K. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: a meta-analysis. Am J Emerg Med. 2020;38(3):641\u20137.","journal-title":"Am J Emerg Med"},{"issue":"3","key":"2191_CR13","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.eprac.2021.11.083","volume":"28","author":"P Hashemi Moghanjoughi","year":"2022","unstructured":"Hashemi Moghanjoughi P, Neshat S, Rezaei A, Heshmat-Ghahdarijani K. Is the neutrophil-to-lymphocyte ratio an exceptional indicator for metabolic syndrome disease and outcomes? Endocr Pract. 2022;28(3):342\u20138.","journal-title":"Endocr Pract"},{"key":"2191_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jad.2022.04.092","volume":"309","author":"Y Wei","year":"2022","unstructured":"Wei Y, Feng J, Ma J, Chen D, Chen J. Neutrophil\/lymphocyte, platelet\/lymphocyte and monocyte\/lymphocyte ratios in patients with affective disorders. J Affect Disord. 2022;309:221\u20138.","journal-title":"J Affect Disord"},{"key":"2191_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577398","volume":"349","author":"A Sayed","year":"2020","unstructured":"Sayed A, Bahbah EI, Kamel S, Barreto GE, Ashraf GM, Elfil M. The neutrophil-to-lymphocyte ratio in Alzheimer\u2019s disease: current understanding and potential applications. J Neuroimmunol. 2020;349: 577398.","journal-title":"J Neuroimmunol"},{"issue":"8","key":"2191_CR16","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/s41440-019-0245-3","volume":"42","author":"YH Jhuang","year":"2019","unstructured":"Jhuang YH, Kao TW, Peng TC, Chen WL, Li YW, Chang PK, Wu LW. Neutrophil to lymphocyte ratio as predictor for incident hypertension: a 9-year cohort study in Taiwan. Hypertens Res. 2019;42(8):1209\u201314.","journal-title":"Hypertens Res"},{"issue":"4","key":"2191_CR17","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41440-023-01195-0","volume":"46","author":"JP Xu","year":"2023","unstructured":"Xu JP, Zeng RX, Zhang YZ, Lin SS, Tan JW, Zhu HY, Mai XY, Guo LH, Zhang MZ. Systemic inflammation markers and the prevalence of hypertension: a NHANES cross-sectional study. Hypertens Res. 2023;46(4):1009\u201319.","journal-title":"Hypertens Res"},{"issue":"1","key":"2191_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1586\/erc.12.159","volume":"11","author":"T Bhat","year":"2013","unstructured":"Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G, Meghani M, Akhtar M, Costantino T. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther. 2013;11(1):55\u20139.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"1","key":"2191_CR19","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41598-020-79431-7","volume":"11","author":"M Song","year":"2021","unstructured":"Song M, Graubard BI, Rabkin CS, Engels EA. Neutrophil-to-lymphocyte ratio and mortality in the United States general population. Sci Rep. 2021;11(1):464.","journal-title":"Sci Rep"},{"issue":"1","key":"2191_CR20","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001\u20132018. Cardiovasc Diabetol. 2023;22(1):279.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2191_CR21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.46124","volume":"5","author":"Y Liu","year":"2022","unstructured":"Liu Y, Geng T, Wan Z, Lu Q, Zhang X, Qiu Z, Li L, Zhu K, Liu L, Pan A, et al. Associations of serum folate and vitamin B12 levels with cardiovascular disease mortality among patients with type 2 diabetes. JAMA Netw Open. 2022;5(1): e2146124.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2191_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s12933-023-02038-5","volume":"22","author":"L Tan","year":"2023","unstructured":"Tan L, Liu Y, Liu J, Zhang G, Liu Z, Shi R. Association between insulin resistance and uncontrolled hypertension and arterial stiffness among US adults: a population-based study. Cardiovasc Diabetol. 2023;22(1):311.","journal-title":"Cardiovasc Diabetol"},{"issue":"18","key":"2191_CR23","doi-asserted-by":"publisher","first-page":"14378","DOI":"10.3390\/ijms241814378","volume":"24","author":"BS Tudurachi","year":"2023","unstructured":"Tudurachi BS, Anghel L, Tudurachi A, Sasc\u0103u RA, St\u0103tescu C. Assessment of inflammatory hematological ratios (NLR, PLR, MLR, LMR and monocyteHDL-cholesterol ratio) in acute myocardial infarction and particularities in young patients. Int J Mol Sci. 2023;24(18):14378.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2191_CR24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12933-023-01986-2","volume":"22","author":"F Yang","year":"2023","unstructured":"Yang F, Wang M, Chen Y, Wu J, Li Y. Association of cardio-renal biomarkers and mortality in the U.S.: a prospective cohort study. Cardiovasc Diabetol. 2023;22(1):265.","journal-title":"Cardiovasc Diabetol"},{"issue":"13","key":"2191_CR25","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1016\/j.cgh.2019.03.046","volume":"17","author":"S Ballou","year":"2019","unstructured":"Ballou S, Katon J, Singh P, Rangan V, Lee HN, McMahon C, Iturrino J, Lembo A, Nee J. Chronic diarrhea and constipation are more common in depressed individuals. Clin Gastroenterol Hepatol. 2019;17(13):2696\u2013703.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"2191_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.23584","volume":"6","author":"Y Li","year":"2023","unstructured":"Li Y, Xia PF, Geng TT, Tu ZZ, Zhang YB, Yu HC, Zhang JJ, Guo K, Yang K, Liu G, et al. Trends in self-reported adherence to healthy lifestyle behaviors among US adults, 1999 to March 2020. JAMA Netw Open. 2023;6(7): e2323584.","journal-title":"JAMA Netw Open"},{"key":"2191_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ejim.2023.03.026","volume":"112","author":"X Zhang","year":"2023","unstructured":"Zhang X, Wang X, Wang M, Qu H, Hu B, Li Q. Prevalence, awareness, and treatment of isolated diastolic hypertension in the United States. Eur J Intern Med. 2023;112:93\u20139.","journal-title":"Eur J Intern Med"},{"issue":"2","key":"2191_CR28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2337\/dc22-1339","volume":"46","author":"B Li","year":"2023","unstructured":"Li B, Chen L, Hu X, Tan T, Yang J, Bao W, Rong S. Association of serum uric acid with all-cause and cardiovascular mortality in diabetes. Diabetes Care. 2023;46(2):425\u201333.","journal-title":"Diabetes Care"},{"key":"2191_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154433","volume":"115","author":"DQ Sun","year":"2021","unstructured":"Sun DQ, Jin Y, Wang TY, Zheng KI, Rios RS, Zhang HY, Targher G, Byrne CD, Yuan WJ, Zheng MH. MAFLD and risk of CKD. Metab Clin Exp. 2021;115: 154433.","journal-title":"Metab Clin Exp"},{"issue":"1","key":"2191_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12933-023-01998-y","volume":"22","author":"G Dong","year":"2023","unstructured":"Dong G, Gan M, Xu S, Xie Y, Zhou M, Wu L. The neutrophil-lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes: evidence from the NHANES 2003\u20132016. Cardiovasc Diabetol. 2023;22(1):267.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2191_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12874-017-0332-6","volume":"17","author":"AN Kamarudin","year":"2017","unstructured":"Kamarudin AN, Cox T, Kolamunnage-Dona R. Time-dependent ROC curve analysis in medical research: current methods and applications. BMC Med Res Methodol. 2017;17(1):53.","journal-title":"BMC Med Res Methodol"},{"key":"2191_CR32","doi-asserted-by":"publisher","first-page":"1098725","DOI":"10.3389\/fimmu.2022.1098725","volume":"13","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Zhao L, Zhou X, Meng X, Zhou X. Role of inflammation, immunity, and oxidative stress in hypertension: new insights and potential therapeutic targets. Front Immunol. 2023;13:1098725.","journal-title":"Front Immunol"},{"issue":"7","key":"2191_CR33","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.3390\/ijms23073636","volume":"23","author":"A Buonacera","year":"2022","unstructured":"Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases. Int J Mol Sci. 2022;23(7):3636.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2191_CR34","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12872-023-03316-6","volume":"23","author":"CC Wu","year":"2023","unstructured":"Wu CC, Wu CH, Lee CH, Cheng CI. Association between neutrophil percentage-to-albumin ratio (NPAR), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and long-term mortality in community-dwelling adults with heart failure: evidence from US NHANES 2005\u20132016. BMC Cardiovasc Disord. 2023;23(1):312.","journal-title":"BMC Cardiovasc Disord"},{"issue":"16","key":"2191_CR35","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1161\/CIRCULATIONAHA.119.045102","volume":"141","author":"M Siedlinski","year":"2020","unstructured":"Siedlinski M, Jozefczuk E, Xu X, Teumer A, Evangelou E, Schnabel RB, Welsh P, Maffia P, Erdmann J, Tomaszewski M, et al. White blood cells and blood pressure. Circulation. 2020;141(16):1307\u201317.","journal-title":"Circulation"},{"issue":"8","key":"2191_CR36","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/cvr\/cvaa336","volume":"117","author":"JE Hall","year":"2021","unstructured":"Hall JE, Mouton AJ, da Silva AA, Omoto ACM, Wang Z, Li X, do Carmo JM. Obesity, kidney dysfunction, and inflammation: interactions in hypertension. Cardiovasc Res. 2021;117(8):1859\u201376.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"2191_CR37","doi-asserted-by":"publisher","first-page":"266","DOI":"10.2174\/1574884711308040002","volume":"8","author":"DA Duarte","year":"2013","unstructured":"Duarte DA, Silva KC, Rosales MA, Lopes de Faria JB, Lopes de Faria JM. The concomitance of hypertension and diabetes exacerbating retinopathy: the role of inflammation and oxidative stress. Curr Clin Pharmacol. 2013;8(4):266\u201377.","journal-title":"Curr Clin Pharmacol"},{"issue":"10","key":"2191_CR38","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/ajh\/hpab094","volume":"34","author":"J Youwakim","year":"2021","unstructured":"Youwakim J, Girouard H. Inflammation: A Mediator Between Hypertension and Neurodegenerative Diseases. Am J Hypertens. 2021;34(10):1014\u201330.","journal-title":"Am J Hypertens"},{"key":"2191_CR39","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2147\/TCRM.S393135","volume":"18","author":"L Li","year":"2022","unstructured":"Li L, Shen Q, Rao S. Association of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with diabetic kidney disease in Chinese patients with type 2 diabetes: a cross-sectional study. Ther Clin Risk Manag. 2022;18:1157\u201366.","journal-title":"Ther Clin Risk Manag"},{"key":"2191_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.700224","volume":"12","author":"S Wang","year":"2021","unstructured":"Wang S, Dong L, Pei G, Jiang Z, Qin A, Tan J, Tang Y, Qin W. High neutrophil-to-lymphocyte ratio is an independent risk factor for end stage renal diseases in IgA nephropathy. Front Immunol. 2021;12: 700224.","journal-title":"Front Immunol"},{"issue":"10335","key":"2191_CR41","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/S0140-6736(22)00461-5","volume":"399","author":"S Sethi","year":"2022","unstructured":"Sethi S, De Vriese AS, Fervenza FC. Acute glomerulonephritis. Lancet. 2022;399(10335):1646\u201363.","journal-title":"Lancet"},{"key":"2191_CR42","doi-asserted-by":"publisher","first-page":"1071465","DOI":"10.3389\/fendo.2022.1071465","volume":"13","author":"W Guo","year":"2022","unstructured":"Guo W, Song Y, Sun Y, Du H, Cai Y, You Q, Fu H, Shao L. Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: evidence from NHANES 2011\u20132018. Front Endocrino. 2022;13:1071465.","journal-title":"Front Endocrino"},{"issue":"3","key":"2191_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0266317","volume":"17","author":"BS Kim","year":"2022","unstructured":"Kim BS, Yu MY, Kim HJ, Lee JH, Shin JH, Shin J. Impact of the estimated glomerular filtration rate on long-term mortality in patients with hypertensive crisis visiting the emergency department. PLoS ONE. 2022;17(3): e0266317.","journal-title":"PLoS ONE"},{"issue":"10","key":"2191_CR44","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s11906-022-01203-7","volume":"24","author":"JS Clemmer","year":"2022","unstructured":"Clemmer JS, Shafi T, Obi Y. Physiological mechanisms of hypertension and cardiovascular disease in end-stage kidney disease. Curr Hypertens Rep. 2022;24(10):413\u201324.","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"2191_CR45","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1161\/HYPERTENSIONAHA.119.13642","volume":"75","author":"AMK Rothman","year":"2020","unstructured":"Rothman AMK, MacFadyen J, Thuren T, Webb A, Harrison DG, Guzik TJ, Libby P, Glynn RJ, Ridker PM. Effects of interleukin-1\u03b2 inhibition on blood pressure, incident hypertension, and residual inflammatory risk. Hypertension. 2020;75(2):477\u201382.","journal-title":"Hypertension"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02191-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-024-02191-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02191-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T09:08:30Z","timestamp":1712048910000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-024-02191-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2191"],"URL":"https:\/\/doi.org\/10.1186\/s12933-024-02191-5","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,2]]},"assertion":[{"value":"25 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the National Center for Health Statistics NCHS Research Ethics Review Board. All participants signed the informed consent before participating in this survey.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}